Left Main Coronary Artery (LMCA) and Bifurcation Disease: Stent or Bypass?

What is the left main coronary artery (LMCA)?

The left main coronary artery (LMCA) arises from the aortic root and supplies much of the left heart. After a short trunk it usually divides into the left anterior descending (LAD) and left circumflex (LCx) arteries. Narrowing of the LMCA can therefore affect a large myocardial territory.

Diagnosis is often made by coronary angiography. Intermediate stenoses should not be judged by percentage alone; physiological testing or intravascular imaging may add useful information.

What is bifurcation disease?

A coronary bifurcation is where a main vessel divides into two branches. Distal LMCA bifurcation refers to the LMCA division into the LAD and LCx. When disease involves this segment, stent planning depends on the main vessel, the side branch and lesion geometry.

Not every bifurcation is treated the same way. A single-stent (provisional) approach may suffice in many cases; planned two-stent strategies may be discussed in more complex true bifurcations. Technical context is also covered on the bifurcation and LMCA interventions page.

What determines stent versus bypass for LMCA disease?

The decision is not based on stenosis percentage alone. Clinical assessment usually includes:

• Location and anatomical complexity (for example distal LMCA bifurcation)
• The SYNTAX score
• The likelihood of complete revascularization with PCI or CABG
• Surgical risk and comorbidities
• Local expertise and patient preference

When both options are technically feasible, Heart Team review is central.

What does the SYNTAX score mean?

The SYNTAX score describes coronary anatomical complexity. In left main disease, guidelines use it to frame PCI versus CABG. A lower score suggests less complex anatomy; a higher score suggests greater complexity. The score does not decide treatment by itself; it is read with clinical status and the chance of complete revascularization.

When may left-main stenting be considered?

PCI (stenting) may be discussed in selected LMCA patients. In the 2024 ESC guideline:

• When SYNTAX is ≤22 and PCI can achieve a similar degree of complete revascularization to CABG, PCI is recommended as a Class I / Level A alternative to CABG.
• When SYNTAX is 23–32 under the same complete-revascularization condition, PCI may be considered at Class IIa / Level A.

These statements do not mean stenting equals bypass in every anatomy. Intermediate LMCA stenoses that look about 40–70% should not be interpreted by angiographic percentage alone; FFR/iFR and/or IVUS/OCT may help clinical judgment.

When is bypass more often discussed?

For significant left main disease at low surgical risk, CABG is generally the preferred revascularization method in the 2024 ESC framework. More complex anatomy, multivessel disease and situations in which PCI is less likely to achieve a similar degree of complete revascularization strengthen the case for surgery. The choice remains individual; it is not “bypass for every LMCA.”

Key differences between PCI / stenting and CABG / bypass

Stenting (PCI) treats the narrowing through a catheter and is usually linked with a shorter hospital stay. CABG bypasses stenoses with surgical grafts; it is more invasive but, in selected anatomies, may reduce later repeat revascularization. The table below summarizes typical differences without declaring a winner.

What did the EXCEL trial show?

EXCEL compared PCI with CABG in 1,905 patients with left main disease of low-to-intermediate anatomical complexity. At five years the composite of death, stroke or myocardial infarction was 22.0% with PCI and 19.2% with CABG (p=0.13). All-cause mortality was 13.0% versus 9.9%, and ischemia-driven repeat revascularization 16.9% versus 10.0%. These results should not be presented as complete equivalence of PCI and CABG; scientific debate continues around the myocardial-infarction definition and trial interpretation.

What did the NOBLE trial show?

NOBLE enrolled 1,201 patients. At about five years, MACCE was 28% with PCI and 19% with CABG; PCI did not meet noninferiority. The difference was driven particularly by non-procedural myocardial infarction and repeat revascularization. The trial should not be used to claim a standalone mortality superiority message.

In an individual-patient-data meta-analysis of SYNTAX, PRECOMBAT, NOBLE and EXCEL (4,394 patients), five-year all-cause mortality was 11.2% with PCI and 10.2% with CABG (HR 1.10; p=0.33). No large mortality difference was shown; spontaneous myocardial infarction and repeat revascularization were more frequent after PCI, while CABG had about a 1% absolute higher first-year stroke risk. This context balances reading EXCEL alone.

One stent or two for LMCA bifurcation?

For distal LMCA bifurcation, a stepwise provisional strategy (main-vessel stent first, side-branch stent only if needed) can often be the default. More complex true distal unprotected left main bifurcations may lead to planned two-stent strategies. Choice depends on lesion anatomy and team expertise; neither “one stent always” nor “two stents always” is appropriate.

How should EBC MAIN and DKCRUSH-V be read together?

EBC MAIN compared stepwise provisional and systematic dual stenting in true left main bifurcation disease and found no significant difference in the 12-month primary composite endpoint. Provisional treatment can therefore be described as a default approach in many LM bifurcations.

DKCRUSH-V, in true distal unprotected left main bifurcations, reported three-year target-lesion failure of 16.9% with provisional treatment and 8.3% with DK-crush, and definite/probable stent thrombosis of 4.1% versus 0.4%. Those results apply especially to complex true distal LM bifurcations; DK-crush is not an automatic preference for every bifurcation.

Why does IVUS / intravascular imaging matter?

Intravascular ultrasound (IVUS) and optical coherence tomography (OCT) can support left main PCI planning through lesion length, vessel size, stent placement and optimization. The 2026 EAPCI / European Bifurcation Club consensus supports this guidance strongly in left main PCI. That support should not be turned into an absolute rule that IVUS is mandatory in every patient; clinical context and technical planning remain decisive.

What is Heart Team assessment?

A Heart Team is a multidisciplinary review involving interventional cardiology, cardiac surgery and related clinicians. When both PCI and CABG are technically feasible, anatomy, surgical risk, expected complete revascularization, local expertise and patient preference are considered together. The aim is not to declare a winner but to choose the option that fits the individual patient.

In brief: stent or bypass for LMCA disease?

For left main or bifurcation disease, the choice between PCI (stenting) and CABG is not made by stenosis percentage alone. Anatomy, the SYNTAX score, the chance of complete revascularization, surgical risk and patient preference are assessed together. Guidelines generally prefer CABG for significant left main disease at low surgical risk, while framing PCI as an alternative in selected low- or intermediate-complexity anatomy. Trial results support that framing; they do not justify universal equivalence or superiority from a single study.